On February 23, 2021, Precision ADVANCE’s Anshul Mangal moderated “Considerations for Early-Stage Gene Therapy Start-Ups: From Clinical Development to Manufacturing to Commercialization,” at the Gene Therapy for Rare Disorders virtual conference. Project Farma’s Tony Khoury and Precision’s Philip Cyr and David Parker joined a panel of industry experts for an update on the status of their current pipelines and development process, as well as a discussion of their unique experiences leading early stage gene therapy companies, the challenges they faced and lessons learned.
To watch the on-demand video of the ADVANCE panel presentation, please click here!
The following day, Precision for Medicine’s Deborah Phippard presented “Planning for Success: Development of Diagnostic Assays for Gene Therapies”, where she provided real-world insights leading to successful development of gene therapy assays. Kristin Ingrassia also presented “Challenges and Mitigations in Gene Therapy Rare Disease Trial Feasibility and Start-up” where she shared best practices for starting up a gene therapy study. Both presentations also discussed more about Precision ADVANCE, interconnected services from Precision for Medicine, Project Farma and Precision Value & Health focused on conquering the complexities of bringing a gene therapy from lab to market.
To watch a video of Deborah’s clinical presentation, click here!
To watch a video of Kristin’s clinical presentation, click here!